JPH1087425A - Oil and water mixture composition - Google Patents
Oil and water mixture compositionInfo
- Publication number
- JPH1087425A JPH1087425A JP8267789A JP26778996A JPH1087425A JP H1087425 A JPH1087425 A JP H1087425A JP 8267789 A JP8267789 A JP 8267789A JP 26778996 A JP26778996 A JP 26778996A JP H1087425 A JPH1087425 A JP H1087425A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- phase component
- water mixture
- mixture composition
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 16
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 17
- 239000007787 solid Substances 0.000 claims abstract description 17
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- 235000019198 oils Nutrition 0.000 claims description 27
- 239000012071 phase Substances 0.000 claims description 19
- 235000019476 oil-water mixture Nutrition 0.000 claims description 16
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 239000003906 humectant Substances 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 6
- 239000004200 microcrystalline wax Substances 0.000 abstract description 5
- 235000019808 microcrystalline wax Nutrition 0.000 abstract description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 3
- 238000013329 compounding Methods 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229940114937 microcrystalline wax Drugs 0.000 abstract 1
- 230000002123 temporal effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 26
- 239000000839 emulsion Substances 0.000 description 11
- 238000011156 evaluation Methods 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- -1 mokuro Substances 0.000 description 6
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- 229940057995 liquid paraffin Drugs 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 235000017709 saponins Nutrition 0.000 description 2
- 239000011863 silicon-based powder Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019156 vitamin B Nutrition 0.000 description 2
- 239000011720 vitamin B Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- RBCOYOYDYNXAFA-UHFFFAOYSA-L (5-hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(C)=C1O RBCOYOYDYNXAFA-UHFFFAOYSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 240000000912 Macadamia tetraphylla Species 0.000 description 1
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- TUYRNAGGIJZRNM-LBHUVFDKSA-N [(2s)-2-[(2r)-4-hexadecanoyloxy-3-hydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethyl] hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(OC(=O)CCCCCCCCCCCCCCC)=C1O TUYRNAGGIJZRNM-LBHUVFDKSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 1
- NRTJGTSOTDBPDE-UHFFFAOYSA-N [dimethyl(methylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[SiH2]O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C NRTJGTSOTDBPDE-UHFFFAOYSA-N 0.000 description 1
- 230000003679 aging effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- BDDKEDZZQGWCDR-UHFFFAOYSA-N hexadecan-7-ol;icosan-9-ol Chemical compound CCCCCCCCCC(O)CCCCCC.CCCCCCCCCCCC(O)CCCCCCCC BDDKEDZZQGWCDR-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008975 pantethine Nutrition 0.000 description 1
- 229960000903 pantethine Drugs 0.000 description 1
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 description 1
- 239000011581 pantethine Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Landscapes
- Compositions Of Macromolecular Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、化粧料や医薬品基
剤として用いられる油水混合組成物に関し、さらに詳し
くは、経時安定性、安全性に優れ、べたつきや肌への異
和感が少なく、肌の乾燥を防ぐ保湿効果が大きく、その
効果の持続性に優れた油水混合組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an oil-water mixture composition used as a cosmetic or pharmaceutical base, and more particularly, it is excellent in stability over time and safety, has less stickiness and discomfort to the skin, The present invention relates to an oil-water mixture composition having a large moisturizing effect for preventing skin dryness and having an excellent durability.
【0002】[0002]
【従来の技術】化粧料や医薬品には、乳液、クリームや
軟膏等のように、水相成分と油相成分とを主要成分とす
る水中油型エマルションまたは油中水型エマルションを
剤型とするものがある。従来、これらの水中油型エマル
ションまたは油中水型エマルションを製造する際には、
界面活性剤が用いられるのが普通である。しかし、従来
用いられている界面活性剤は、皮膚に刺激を感じる場合
もあり、不安を抱く消費者も多い。また、これらの界面
活性剤を用いた水中油型エマルションや油中水型エマル
ションは、経時的に不安定であったり、べたつきのある
使用感となって官能的に好ましくなく、さらに耐水性に
劣る等の問題があった。このような背景から、界面活性
剤の使用量をできるだけ少なくしたり、界面活性剤を使
用しないエマルションが開発されるようになってきた。
例えば、界面活性剤の代わりに粘土鉱物(特開昭56−
150007号、特開昭57−16812号、特公昭6
4−3529号、特開昭58−124535号)、シリ
コーンオイル(特開昭61−66527号)、グリチル
リチン(特開昭57−62214号)等を乳化剤あるい
は乳化助剤として用いたエマルションが知られている。2. Description of the Related Art In cosmetics and pharmaceuticals, oil-in-water emulsions or water-in-oil emulsions containing an aqueous phase component and an oil phase component as main components, such as emulsions, creams and ointments, are used as dosage forms. There is something. Conventionally, when producing these oil-in-water emulsions or water-in-oil emulsions,
Surfactants are usually used. However, conventionally used surfactants may cause irritation to the skin, and many consumers have anxiety. In addition, oil-in-water emulsions and water-in-oil emulsions using these surfactants are unstable with time, or become organoleptically unpleasant to give a sticky feeling of use, and further have poor water resistance. And so on. Against this background, emulsions that use as little surfactant as possible and that do not use surfactants have been developed.
For example, a clay mineral (Japanese Unexamined Patent Publication No.
No. 150007, Japanese Patent Application Laid-Open No. 57-16812, Japanese Patent Publication No. Sho 6
Emulsions using, as an emulsifier or an emulsifying aid, silicone oil (Japanese Patent Application Laid-Open No. Sho 61-66527), glycyrrhizin (Japanese Patent Application Laid-Open No. 57-62214), and the like are known. ing.
【0003】[0003]
【発明が解決しようとする課題】しかし、このようない
わゆる界面活性剤を用いないエマルションは、経時的に
安定なエマルションを得るのが非常に困難であったり、
感触や安全性上の問題を十分に解決したものとは言い難
い。本発明はこのような観点からなされたものであり、
実質的に乳化剤としての界面活性剤を用いずに、経時安
定性、安全性に優れ、べたつきや肌への異和感が少な
く、肌の乾燥を防ぐ保湿効果が大きく、その効果の持続
性に優れた油水混合組成物を提供することを目的とす
る。However, such an emulsion not using a surfactant is very difficult to obtain a stable emulsion over time,
It is hard to say that it completely solved the problems of feel and safety. The present invention has been made from such a viewpoint,
Substantially no surfactant as an emulsifier, excellent in stability over time and safety, less sticky and uncomfortable to the skin, great moisturizing effect to prevent drying of the skin, long lasting effect An object is to provide an excellent oil-water mixture composition.
【0004】[0004]
【課題を解決するための手段】本発明者らは、上記課題
を解決するために鋭意検討を行った結果、ポリエーテル
変性シリコーンと常温において固型または半固型状の油
分を特定量含む油相成分と、保湿剤を含有する水相成分
とをある範囲の割合で配合すると、経時安定性、安全性
に優れ、べたつきや肌への異和感が少なく、肌の乾燥を
防ぐ保湿効果が大きく、その効果の持続性に優れる油水
混合組成物が得られることを見い出し、本発明を完成す
るに至った。Means for Solving the Problems The inventors of the present invention have conducted intensive studies to solve the above-mentioned problems, and as a result, have found that polyether-modified silicone and oil containing a specific amount of solid or semi-solid oil at normal temperature are contained. When the phase component and the aqueous phase component containing the humectant are blended in a certain ratio, the aging effect is excellent in stability over time and safety, less sticky and uncomfortable to the skin, and prevents the skin from drying out. The present inventors have found that an oil-water mixture composition which is large and has excellent durability can be obtained, and the present invention has been completed.
【0005】すなわち、本発明は、下記一般式(1)で
表されるポリエーテル変性シリコーンおよび常温におい
て固型または半固型状の油分を含有する油相成分と、保
湿剤を含有する水相成分とを配合したことを特徴とする
油水混合組成物である。That is, the present invention provides an oil phase component containing a polyether-modified silicone represented by the following general formula (1) and a solid or semi-solid oil component at room temperature, and an aqueous phase containing a humectant. It is an oil-water mixture composition characterized by blending components.
【0006】[0006]
【化2】 Embedded image
【0007】(式中、mは50〜1000の整数、nは
1〜40の整数、aおよびbは5〜50の整数であ
る。) 本発明の油水混合組成物は、化粧品や、医薬品、医薬部
外品など、外皮や毛髪に適用されるものに適用可能であ
る。(Wherein, m is an integer of 50 to 1000, n is an integer of 1 to 40, and a and b are integers of 5 to 50.) The oil-water mixture composition of the present invention can be used for cosmetics, pharmaceuticals, The present invention is applicable to quasi-drugs and the like applied to outer skin and hair.
【0008】以下、本発明の構成について詳述する。本
発明の油相成分に含まれるポリエーテル変性シリコーン
は上記一般式(1)で示されるポリオキシアルキレン基
を有するオルガノポリシロキサンであり、例えば特開平
5−311076号公報に開示されているものが挙げら
れる。Hereinafter, the configuration of the present invention will be described in detail. The polyether-modified silicone contained in the oil phase component of the present invention is an organopolysiloxane having a polyoxyalkylene group represented by the above general formula (1). For example, those disclosed in JP-A-5-31076 are disclosed. No.
【0009】なお、ポリオキシアルキレン基において、
aまたはbが5未満である場合には、ポリエーテル変性
シリコーンが十分な経時安定化効果を示さなくなり、ま
たaまたはbが50を超える場合には、得られた油水混
合組成物がべとつき感を有するようになる。In the polyoxyalkylene group,
When a or b is less than 5, the polyether-modified silicone does not show a sufficient time-stabilizing effect, and when a or b exceeds 50, the obtained oil-water mixture composition gives a sticky feeling. Will have.
【0010】ポリオキシアルキレン基の含有量は特に限
定されないが、ポリオキシアルキレン基の含有量が20
重量%を超えるものが望ましい。これは、ポリオキシア
ルキレン基の含有量が20重量%以下の場合には、ポリ
エーテル変性シリコーンの経時安定化効果が著しく低下
するためである。[0010] The content of the polyoxyalkylene group is not particularly limited.
It is desirable to have more than% by weight. This is because when the content of the polyoxyalkylene group is 20% by weight or less, the effect of stabilizing the polyether-modified silicone over time is significantly reduced.
【0011】また、mは50〜1000の整数であり、
nは1〜40の整数であり、好ましくは、mは200〜
600、nは5〜20である。これは、mが50未満で
あり、nが1未満である場合には、経時安定性に乏し
く、またmが1000を超え、かつnが40を超える場
合には、得られた油水混合組成物がべとつき感を有する
ようになるからである。M is an integer of 50 to 1000;
n is an integer of 1 to 40, preferably m is 200 to
600, n is 5-20. This is because when m is less than 50 and n is less than 1, stability over time is poor, and when m exceeds 1000 and n exceeds 40, the obtained oil-water mixed composition This is because it becomes sticky.
【0012】本発明に用いられるポリエーテル変性シリ
コーンの分子量は特に限定されず、またその25℃にお
ける粘度は特に限定されないが、特に安定性のある油水
混合組成物とするためには、本発明に用いられるポリエ
ーテル変性シリコーンは、オクタメチルテトラシロキサ
ンまたはイソパラフィンの50重量%溶液とした時の粘
度が1,000〜100,000cpsの範囲となるよ
うなものであることが好ましい。また分子量は、安定
性、使用性の面から50000以上、好ましくは500
00〜80000の範囲が好ましい。The molecular weight of the polyether-modified silicone used in the present invention is not particularly limited, and its viscosity at 25 ° C. is not particularly limited. The polyether-modified silicone used is preferably one having a viscosity of 1,000 to 100,000 cps in a 50% by weight solution of octamethyltetrasiloxane or isoparaffin. The molecular weight is 50,000 or more, preferably 500, from the viewpoint of stability and usability.
The range of 00 to 80000 is preferred.
【0013】本発明におけるポリエーテル変性シリコー
ンの配合量は油水混合組成物全量に対して0.1〜1
0.0重量%が好ましく、さらに好ましくは0.5〜
5.0重量%である。この配合量が0.1重量%未満で
は、高温における安定性に問題があり、逆に10.0重
量%を越えると、使用性においてべたつきが生じてしま
う。The amount of the polyether-modified silicone in the present invention is 0.1 to 1 with respect to the total amount of the oil-water mixture composition.
0.0% by weight is preferred, and more preferably 0.5 to
5.0% by weight. If the amount is less than 0.1% by weight, there is a problem in stability at high temperatures, and if it exceeds 10.0% by weight, stickiness occurs in usability.
【0014】本発明の油相成分に含まれる常温において
固型または半固型状の油分としては、具体的には、ワッ
クス類(例えばマイクロクリスタリンワックス、ビーズ
ワックス)、固型パラフィン、硬化油、牛脂、モクロ
ウ、ミツロウ、キャンデリラロウ、カルナバロウ、セレ
シン、ワセリン、ラノリン、ラノリン誘導体、高級アル
コール(例えばセタノール、ステアリルアルコール)、
コレステロール、コレステロール誘導体等が挙げられ
る。このうち、効果の面で特に、マイクロクリスタリン
ワックスやワセリンが最も好ましい。このような油分の
配合量は油水混合組成物全量に対して1.0〜70.0
重量%が好ましく、さらに好ましくは5.0〜40.0
重量%である。この配合量が1.0重量%未満では、高
温における安定性に問題があり、逆に70.0重量%を
越えると、硬くなり過ぎて使用しにくくなる。また固型
または半固型油分を用いず、液状油分のみを用いた時
は、経時で離漿がおこる。Examples of the solid or semi-solid oil component at room temperature contained in the oil phase component of the present invention include waxes (eg, microcrystalline wax, beeswax), solid paraffin, hardened oil, Beef tallow, mokuro, beeswax, candelilla wax, carnauba wax, ceresin, vaseline, lanolin, lanolin derivatives, higher alcohols (eg cetanol, stearyl alcohol),
Cholesterol, cholesterol derivatives and the like can be mentioned. Of these, microcrystalline wax and petrolatum are most preferable in terms of effect. The amount of such an oil component is 1.0 to 70.0% based on the total amount of the oil-water mixture composition.
% By weight, more preferably from 5.0 to 40.0% by weight.
% By weight. When the amount is less than 1.0% by weight, there is a problem in stability at a high temperature. On the other hand, when the amount exceeds 70.0% by weight, the material becomes too hard to use. In addition, when only liquid oil is used without using solid or semi-solid oil, syneresis occurs with time.
【0015】本発明の油相成分としては、上記のポリエ
ーテル変性シリコーンおよび常温において固型または半
固型状の油分の他に、タルク、シルクパウダー、ナイロ
ンパウダー、シリコンパウダー、ポリテトラフルオロエ
チレンパウダー、疎水化処理粉末等の粉末成分;流動パ
ラフィン、スクワラン等の炭化水素;オリーブ油、マカ
デミアナッツ油、椿油、ホホバ油、液状ラノリンなどの
動植物抽出油;シリコーン油、パーフルオロ化油、脂肪
酸、オクタノール、ヘキシルデカノール、オクチルドデ
カノール等の高級アルコール;ミリスチン酸イソプロピ
ル、ミリスチン酸オクチルドデシル、パルミチン酸イソ
プロピル等;各種薬剤としては、ビタミンA及びその誘
導体、アスコルビン酸ジパルミテート、α−トコフェロ
ール、β−トコフェロール、γ−トコフェロール、ビタ
ミンEアセテート、ビタミンEニコチネート、ビタミン
D類等のビタミン類;ニコチン酸アミド、ニコチン酸ベ
ンジル、γ−オリザノール、ビサボロール、チモール、
パントテニルエチルエーテル、エチニルエストラジオー
ル、香料、油溶性酸化防止剤、油溶性紫外線吸収剤等を
含ませることができる。As the oil phase component of the present invention, in addition to the above-mentioned polyether-modified silicone and a solid or semi-solid oil at normal temperature, talc, silk powder, nylon powder, silicone powder, polytetrafluoroethylene powder And powder components such as hydrophobized powder; hydrocarbons such as liquid paraffin and squalane; animal and plant extracted oils such as olive oil, macadamia nut oil, camellia oil, jojoba oil, and liquid lanolin; silicone oils, perfluorinated oils, fatty acids, octanol, hexyldecanol Octyldodecanol, octyldodecanol, etc .; isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, etc .; various drugs include vitamin A and its derivatives, ascorbic acid dipalmitate, α-tocopherol, β-tocophere. Rolls, γ-tocopherol, vitamin E acetate, vitamin E nicotinate, vitamins such as vitamin D; nicotinamide, benzyl nicotinate, γ-oryzanol, bisabolol, thymol,
Pantothenyl ethyl ether, ethinyl estradiol, fragrance, oil-soluble antioxidant, oil-soluble ultraviolet absorber and the like can be contained.
【0016】本発明において、油相は連続相を形成して
いることが好ましい。In the present invention, the oil phase preferably forms a continuous phase.
【0017】本発明に用いられる保湿剤としては、ポリ
エチレングリコール、プロピレングリコール、ジプロピ
レングリコール、1,3−ブチレングリコール、グリセ
リン、ジグリセリン、ソルビトール、マルチトール、ム
コ多糖、ヒアルロン酸、コンドロイチン硫酸、エリスリ
トール、トリメチルグリシン、乳酸、乳酸ナトリウム、
ピロリドンカルボン酸ナトリウム等が挙げられる。その
うち、安定性と肌あれ改善効果の面で特に、1,3−ブ
チレングリコール、グリセリンが最も好ましい。これら
の保湿剤の配合量は油水混合組成物全量に対して1.0
〜70.0重量%が好ましく、さらに好ましくは5.0
〜40.0重量%である。この配合量が1.0重量%未
満では、高温における安定性に問題があり、逆に70.
0重量%を越えると、べたつき過ぎて使用性が悪くな
る。The humectant used in the present invention includes polyethylene glycol, propylene glycol, dipropylene glycol, 1,3-butylene glycol, glycerin, diglycerin, sorbitol, maltitol, mucopolysaccharide, hyaluronic acid, chondroitin sulfate, erythritol , Trimethylglycine, lactic acid, sodium lactate,
And sodium pyrrolidonecarboxylate. Among them, 1,3-butylene glycol and glycerin are most preferable in terms of stability and skin roughness improving effect. The compounding amount of these humectants is 1.0 to the total amount of the oil-water mixture composition.
To 70.0% by weight, more preferably 5.0% by weight.
440.0% by weight. When the amount is less than 1.0% by weight, there is a problem in stability at a high temperature.
If it exceeds 0% by weight, the stickiness becomes too sticky and the usability deteriorates.
【0018】本発明の水相成分としては、上記の保湿剤
の他に、酸化チタン、マイカ、セルロースパウダー等の
粉末成分;防腐剤としてパラオキシ安息香酸エステル、
安息香酸、安息香酸ナトリウム、ソルビン酸、ソルビン
酸カリウム、フェノキシエタノール等;各種薬剤とし
て、ビタミンB6塩酸塩、ビタミンB6トリパルミテー
ト、ビタミンB6ジオクタノエート、ビタミンB2及びそ
の誘導体、ビタミンB12、ビタミンB15及びその誘導体
等のビタミンB類、アスコルビン酸、アスコルビン酸硫
酸エステル(塩)、アスコルビン酸リン酸エステル
(塩)、アスコルビン酸ジグルコシド等のビタミンC
類、ビタミンH、パントテン酸、パンテチン等のビタミ
ン類;アラントイン、グリチルリチン酸(塩)、グリチ
ルレチン酸及びその誘導体、ヒノキチオール、イノシト
ール、サポニン類(サイコサポニン、ニンジンサポニ
ン、ヘチマサポニン、ムクロジサポニン類)、トラネキ
サム酸、プラセンタエキス、色素、金属封鎖剤、水溶性
酸化防止剤、水溶性紫外線吸収剤、被膜剤等を含ませる
ことができる。The aqueous phase component of the present invention includes, in addition to the above humectants, powder components such as titanium oxide, mica and cellulose powder; paraoxybenzoic acid esters as preservatives;
Benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, phenoxyethanol, etc .; as various drugs, vitamin B 6 hydrochloride, vitamin B 6 tripalmitate, vitamin B 6 dioctanoate, vitamin B 2 and its derivatives, vitamin B 12 , vitamin B such as vitamin B 15 and its derivatives, ascorbic acid, ascorbic acid sulfate ester (salt), ascorbic acid phosphate ester (salt), vitamin C such as ascorbic acid diglucoside
, Vitamins such as vitamin H, pantothenic acid, and pantethine; allantoin, glycyrrhizic acid (salt), glycyrrhetinic acid and its derivatives, hinokitiol, inositol, saponins (psychosaponins, carrot saponins, hemimasaponins, muclodisaponins), tranexam An acid, a placenta extract, a pigment, a sequestering agent, a water-soluble antioxidant, a water-soluble ultraviolet absorber, a coating agent and the like can be contained.
【0019】本発明において、油相成分と水相成分との
比(重量比)は、油相成分:水相成分=1:4〜4:1
が好ましい。油相成分と水相成分との比がこの範囲をは
ずれると、離漿や油うきがおこる。In the present invention, the ratio (weight ratio) of the oil phase component to the aqueous phase component is such that the ratio of the oil phase component to the aqueous phase component is 1: 4 to 4: 1.
Is preferred. If the ratio of the oil phase component to the water phase component is out of this range, syneresis and oiliness occur.
【0020】本発明の油水混合組成物には、前記必須成
分の他に、化粧品や医薬品等の皮膚外用剤に一般的に用
いられる界面活性剤以外の成分を、本発明の所望の効果
を損なわない範囲で配合することができる。In the oil-water mixture composition of the present invention, in addition to the above essential components, components other than surfactants generally used in external preparations for skin such as cosmetics and pharmaceuticals impair the desired effects of the present invention. It can be blended in a range that does not exist.
【0021】[0021]
【実施例】以下に本発明の実施例を示し、本発明を更に
詳細に説明するが、本発明はこれらの実施例によって限
定されるものではない。実施例に先立ち、本発明の効果
試験の評価項目および評価基準に関して詳述する。The present invention will be described in more detail with reference to examples of the present invention, but the present invention is not limited to these examples. Prior to Examples, evaluation items and evaluation criteria of the effect test of the present invention will be described in detail.
【0022】(1) 安定性評価試験 各試料を、−10℃、0℃、5℃、30℃、45℃の恒
温槽に3ヶ月間保存し、色調、臭い、外観性状および使
用感の変化について下記の基準によって評価した。 (評価基準) ◎:色調・臭い・外観性状・使用感のいずれにも全く変
化がない。 ○:色調・臭い・外観性状・使用感のいずれにもほとん
ど変化がない。 ×:色調・臭い・外観性状・使用感のいずれかに変化が
見られた。(1) Stability evaluation test Each sample was stored in a thermostat at -10 ° C, 0 ° C, 5 ° C, 30 ° C, and 45 ° C for 3 months, and changes in color tone, odor, appearance properties, and usability were observed. Was evaluated according to the following criteria. (Evaluation criteria) A: There is no change in any of color tone, smell, appearance properties, and feeling of use. :: There is almost no change in any of color tone, smell, appearance properties, and usability. X: Change was observed in any of color tone, smell, appearance properties, and feeling of use.
【0023】(2) 官能評価試験 女性パネラー30名に各試料を使用してもらい、べたつ
き、肌への異和感、しっとり感およびしっとり感の持続
性について、下記表1の基準により評価点を求めた。(2) Sensory evaluation test Thirty female panelists used each sample, and evaluated the stickiness, uncomfortable feeling to the skin, moist feeling and the persistence of moist feeling according to the criteria in Table 1 below. I asked.
【0024】(3) 有用性試験 女性パネラー20名により、顔に各試料を毎晩1ヵ月間
使用してもらい、肌あれ改善効果について、下記表1の
基準によって評価点を求めた。(3) Utility test Twenty female panelists asked each face to use each sample for one month every night, and the effect of improving skin roughness was evaluated according to the criteria shown in Table 1 below.
【0025】[0025]
【表1】 [Table 1]
【0026】求めた評価点をもとに、次の基準により試
料を評価した。 ○:評価点平均1.5点以上。 △:評価点平均0.5点以上、1.5点未満。 ×:評価点平均0.5点未満。Based on the obtained evaluation points, the samples were evaluated according to the following criteria. :: 1.5 or more evaluation points average. Δ: Evaluation point average 0.5 points or more and less than 1.5 points. X: Evaluation point average is less than 0.5 point.
【0027】実施例1〜5、比較例1〜6 表2〜表3に示す処方により、実施例1〜5および比較
例1〜6の化粧料を調製し、前記評価試験を行った。試
験結果は表4に記載した。なお、これら化粧料の調製
は、油相と水相を溶解混合後、攪拌冷却させる方法によ
って行った。表2〜3の配合量は重量%である。Examples 1 to 5 and Comparative Examples 1 to 6 The cosmetics of Examples 1 to 5 and Comparative Examples 1 to 6 were prepared according to the formulations shown in Tables 2 and 3, and the evaluation test was performed. The test results are shown in Table 4. In addition, these cosmetics were prepared by a method in which an oil phase and an aqueous phase were dissolved and mixed, followed by stirring and cooling. The blending amounts in Tables 2 and 3 are% by weight.
【0028】[0028]
【表2】 ──────────────────────────────── 実 施 例 ─────────────── 1 2 3 4 5 ──────────────────────────────── 水相 精製水 5.0 35.0 20.0 15.0 10.0 グリセリン 10.0 5.0 − − − 1,3−ブチレングリコール − − 10.0 5.0 − ポリエチレングリコール1500 20.0 10.0 15.0 − 15.0 ポリエチレングリコール6000 5.0 5.0 − − − ポリエチレングリコール20000 − 5.0 5.0 − 15.0 セルロースパウダー − − − 5.0 − ──────────────────────────────── 油相 流動パラフィン 15.0 20.0 18.0 − 15.0 スクワラン − − − 19.0 − ジメチルポリシロキサン(5cs) − − − 5.0 − デカメチルシクロペンタシロキサン 25.0 3.0 − 20.0 24.0 ポリエーテル変性シリコーン*1) 8.0 10.0 8.0 6.0 6.0 ワセリン 5.0 − 14.0 10.0 10.0 マイクロクリスタリンワックス 5.0 7.0 10.0 15.0 5.0 シリコンパウダー 2.0 − − − − ────────────────────────────────[Table 2] ──────────────────────────────── Example of implementation ─────────── 1 1 2 3 4 5 ──────────────────────────────── Water phase Purified water 5.0 35.0 20.0 15.0 10.0 Glycerin 10.0 5.0---1,3-butylene glycol--10.0 5.0-Polyethylene glycol 1500 20.0 10.0 15.0-15.0 Polyethylene glycol 6000 5.0 5.0---Polyethylene glycol 20000-5.0 5.0-15.0 Cellulose powder---5.0-──油 Oil phase Liquid paraffin 15.0 20.0 18.0-15.0 Squalane---19.0-Dimethyl polysiloxane (5cs ) − − − 5.0 − Decamethylcyclopentasiloxane 25.0 3.0 − 20.0 24.0 Polyether-modified silicone * 1) 8.0 10.0 8.0 6.0 6.0 Vaseline 5.0 − 14.0 10.0 10.0 Microcrystalline wax 5.0 7.0 10.0 15.0 5.0 Silicon powder 2.0 − − − − ──────────────── ────────────────
【0029】[0029]
【表3】 ───────────────────────────────── 比 較 例 ──────────────── 1 2 3 4 5 6 ───────────────────────────────── 水相 精製水 50.0 18.0 2.0 40.0 35.0 20.0 グリセリン − 6.0 − 5.0 5.0 − 1,3−ブチレングリコール 5.0 − − − − − ポリエチレングリコール1500 5.0 − − 5.0 10.0 − ポリエチレングリコール6000 − − − − 5.0 − ポリエチレングリコール20000 − − 20.0 10.0 5.0 − セルロースパウダー − − − − − 5.0 ───────────────────────────────── 油相 流動パラフィン 15.0 52.0 − 10.0 20.0 − スクワラン − 9.0 3.0 − 7.0 19.0 ジメチルポリシロキサン(5cs) 15.0 − − 20.0 − 5.0 デカメチルシクロペンタシロキサン 10.0 10.0 − 5.0 3.0 20.0 ポリエーテル変性シリコーン*1) − − − − 10.0 6.0 ワセリン − − 35.0 − − 10.0 マイクロクリスタリンワックス − 5.0 40.0 5.0 − 15.0 シリコンパウダー − − − − − − ─────────────────────────────────[Table 3] Comparative example 例────── 1 2 3 4 5 6 ───────────────────────────────── Water phase Purified water 50.0 18.0 2.0 40.0 35.0 20.0 Glycerin-6.0-5.0 5.0-1,3-butylene glycol 5.0-----Polyethylene glycol 1500 5.0--5.0 10.0-Polyethylene glycol 6000----5.0-Polyethylene glycol 20000--20.0 10.0 5.0 − Cellulose powder − − − − − 5.0 ───────────────────────────────── Oil phase Liquid paraffin 15.0 52.0 − 10.0 20.0-Squalane-9.0 3.0-7.0 19.0 Dimethyl polysiloxane (5cs) 15.0--20.0-5.0 Le Cyclopentasiloxane 10.0 10.0 - 5.0 3.0 20.0 Polyether-modified silicone * 1) - - - - 10.0 6.0 Vaseline - - 35.0 - - 10.0 Microcrystalline wax - 5.0 40.0 5.0 - 15.0 Silicon Powder - - - - - - ─── ──────────────────────────────
【0030】[0030]
【表4】 ────────────────────────────────── 実 施 例 比 較 例 ─────────── ──────────── 1 2 3 4 5 1 2 3 4 5 6 ────────────────────────────────── 安定性 ◎ ◎ ◎ ◎ ○ × × ○ ○ × × ────────────────────────────────── 使用性 しっとり感 ○ ○ ○ ○ ○ × × ○ △ ○ × しっとり感の持続性 ○ ○ ○ ○ ○ × × ○ × ○ × 肌への違和感 ○ ○ ○ ○ ○ × × ○ × × × べたつき ○ ○ ○ ○ ○ ○ ○ × △ ○ ○ ────────────────────────────────── 有用性 肌あれ改善効果 ○ ○ ○ ○ △ ○ ○ × ○ ○ × ──────────────────────────────────[Table 4] ────────────────────────────────── Example Comparison Example {1 2 3 4 5 5 1 2 3 4 5 6}安定 Stability ◎ ◎ ◎ ◎ ○ × × ○ ○ × × ─────────────────────────性 Usability Moist feeling ○ ○ ○ ○ ○ × × ○ △ ○ × Persistence of moist feeling ○ ○ ○ ○ ○ × × ○ × ○ × Uncomfortable feeling to skin ○ ○ ○ ○ ○ × × ○ × × × Sticky ○ ○ ○ ○ ○ ○ ○ × △ ○ ○ ───────────────────────────────── ─ Usefulness Skin roughness improvement effect ○ ○ ○ ○ △ ○ ○ × ○ ○ × ───────────────────── ─────────────
【0031】*1) 一般式(1)で、m=400、n=1
0、a=24、b=24* 1) In the general formula (1), m = 400, n = 1
0, a = 24, b = 24
【0032】[0032]
【発明の効果】以上説明したように、本発明の油水混合
組成物は、経時安定性に優れ、べたつきや肌への異和感
が少なく、肌の乾燥を防ぐ保湿効果が大きく、その効果
の持続性に優れたものである。As described above, the oil-water mixture composition of the present invention is excellent in stability over time, less sticky and uncomfortable to the skin, and has a large moisturizing effect for preventing the skin from drying. It has excellent sustainability.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 伊藤 建三 神奈川県横浜市港北区新羽町1050番地 株 式会社資生堂第一リサーチセンター内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Kenzo Ito 1050 Nippa-cho, Kohoku-ku, Yokohama-shi, Kanagawa Prefecture Inside Shiseido Daiichi Research Center Co., Ltd.
Claims (4)
ル変性シリコーンおよび常温において固型または半固型
状の油分を含有する油相成分と、保湿剤を含有する水相
成分とを配合したことを特徴とする油水混合組成物。 【化1】 (式中、mは50〜1000の整数、nは1〜40の整
数、aおよびbは5〜50の整数である。)An oil phase component containing a polyether-modified silicone represented by the following general formula (1), a solid or semi-solid oil component at normal temperature, and an aqueous phase component containing a humectant. An oil-water mixture composition, characterized in that: Embedded image (In the formula, m is an integer of 50 to 1000, n is an integer of 1 to 40, and a and b are integers of 5 to 50.)
ある請求項1記載の油水混合組成物。2. The oil-water mixture composition according to claim 1, wherein the composition does not substantially contain a surfactant.
量に対して0.1〜10.0重量%含有し、常温におい
て固型または半固型状の油分を組成物全量に対して1.
0〜70.0重量%含有し、保湿剤を組成物全量に対し
て1.0〜70.0重量%含有する請求項1または2に
記載の油水混合組成物。3. The polyether-modified silicone is contained in an amount of 0.1 to 10.0% by weight based on the total amount of the composition, and at room temperature, a solid or semi-solid oil component is added to the total amount of the composition.
The oil-water mixture composition according to claim 1, wherein the composition comprises 0 to 70.0% by weight and a humectant in an amount of 1.0 to 70.0% by weight based on the total amount of the composition.
水相成分=1:4〜4:1である請求項1〜3のいずれ
かに記載の油水混合組成物。4. The method according to claim 1, wherein the ratio of the oil phase component to the aqueous phase component is:
The oil-water mixture composition according to any one of claims 1 to 3, wherein the aqueous phase component is 1: 4 to 4: 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8267789A JPH1087425A (en) | 1996-09-18 | 1996-09-18 | Oil and water mixture composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8267789A JPH1087425A (en) | 1996-09-18 | 1996-09-18 | Oil and water mixture composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH1087425A true JPH1087425A (en) | 1998-04-07 |
Family
ID=17449622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8267789A Withdrawn JPH1087425A (en) | 1996-09-18 | 1996-09-18 | Oil and water mixture composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH1087425A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000273308A (en) * | 1999-01-12 | 2000-10-03 | Dow Corning Corp | Production of vitamin-enhanced silicone elastomer |
JP2001048737A (en) * | 1999-07-12 | 2001-02-20 | L'oreal Sa | Solid composition and its use, especially cosmetic use |
-
1996
- 1996-09-18 JP JP8267789A patent/JPH1087425A/en not_active Withdrawn
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000273308A (en) * | 1999-01-12 | 2000-10-03 | Dow Corning Corp | Production of vitamin-enhanced silicone elastomer |
JP2001048737A (en) * | 1999-07-12 | 2001-02-20 | L'oreal Sa | Solid composition and its use, especially cosmetic use |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0763354B1 (en) | Oil/water mixture composition | |
JPH1053510A (en) | Composition for external use | |
JPH026321B2 (en) | ||
JP4406498B2 (en) | Skin cosmetics | |
JP5053562B2 (en) | Emulsified cosmetics | |
JPH09315937A (en) | Gelled composition, emulsion composition and preparation for external use for skin | |
JP2000351712A (en) | Solid water-in-oil type emulsified cosmetic | |
JP3220177B2 (en) | Water-in-oil emulsion cosmetics | |
JP2004307414A (en) | W/o/w emulsion skin care preparation for external use and method for producing the same | |
JP3022541B1 (en) | External preparation | |
JPH1087425A (en) | Oil and water mixture composition | |
JPH1171228A (en) | Water-in-oil emulsion composition | |
JP2001131016A (en) | Composition for external use | |
JP2556730B2 (en) | Skin cosmetics | |
JP2000191499A (en) | Cosmetic for moisturiztng skin | |
JP2002161015A (en) | Cosmetic | |
JPH06287107A (en) | Gel-like emulsion cosmetic | |
JP3242398B2 (en) | Cosmetics | |
JP2002284623A (en) | Cosmetics | |
JPH09124437A (en) | Emulsified composition and dermal preparation for external use | |
JP2003286125A (en) | Water-in-oil type emulsified cosmetic | |
JP2004026748A (en) | Water-in-oil type emulsion cosmetic | |
JPH08183725A (en) | Skin cosmetic | |
JPH10101520A (en) | Preparation for external use for skin | |
JP3421573B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20031202 |